Abbott LaboratoriesABT is slated to report second-quarter 2025 results on July 17, before the opening bell. The company ...

The Pelvic Wellness Center opened in October 2024 to support both women and men's pelvic health. The center offers ...

The single-arm, open-label DR-OVP-002 study is currently evaluating Ovaprene in sexually active women aged 18 to 40 years who are at risk for pregnancy or desiring contraception.